1.25 mg of tirzepatide Injectable – 25 mg/mL Tirzepatide (Zepbound, Mounjaro): Weight Loss,

The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

Vanoli F, Mantegazza R (2022) What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis

Nasal spray (daily or as prescribed) Oral troche (daily or as prescribed) Starting at $187/mo Starting at $149/mo *Individual results vary

Inclusion Criteria Age 16 or older Has completed at least 6 months of structured lifestyle therapy (nutrition, activity, or behavioral support) without achieving desired results Family and teen are willing to commit to a structured program including injections, monitoring, and follow-up care BMI at or above the 95th percentile for age and gender, or above the 85th percentile with health-related conditions such as insulin resistance or high cholesterol